Cancer Cells Employ the Most Prolific RNA Editors: A Closer Look at the Single-Cell Level
1Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas.
Abstract:
Adenosine-to-inosine (A-to-I) RNA editing is a major source of nucleotide diversification that has significant mechanistic implications in cancer progression and treatment response. However, its activity and prevalence have not yet been systematically determined at a single-cell resolution. Chan and colleagues revealed widespread A-to-I RNA editing events in single cancer cells through an in-depth analysis of a public lung adenocarcinoma single-cell transcriptome dataset. Edits significantly enriched in cancer cells compared to other cell types have the potential to inhibit innate immune response and to predict poor therapeutic response and prognosis in patients treated with targeted therapies. See related article by Chan et al., p. 374.
Insights
Adenosine-to-inosine (A-to-I) RNA editing is widespread in single cancer cells, impacting immune response and treatment outcomes. These edits may predict poor prognosis in lung adenocarcinoma patients receiving targeted therapies.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Adenosine-to-inosine (A-to-I) RNA editing diversifies the transcriptome and influences biological processes.
- Its role in cancer progression and therapeutic response is mechanistically significant.
- Systematic analysis at single-cell resolution has been lacking.
Discussion:
- Chan and colleagues analyzed a lung adenocarcinoma single-cell transcriptome dataset to map A-to-I RNA editing.
- Widespread editing events were identified specifically within cancer cells.
- Enrichment of these edits in cancer cells suggests potential roles in immune evasion.
Key Insights:
- Single-cell analysis reveals prevalent A-to-I RNA editing in cancer cells.
- Specific editing patterns correlate with inhibited innate immune responses.
- A-to-I RNA editing can predict poor response to targeted therapies and overall prognosis.
Outlook:
- Further investigation into the functional consequences of cancer-specific A-to-I editing.
- Development of therapeutic strategies targeting RNA editing in cancer.
- Integration of single-cell RNA editing data into clinical decision-making for lung adenocarcinoma.
More Related Videos
Related Concept Videos
RNA Editing
Cancers Originate from Somatic Mutations in a Single Cell
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Base Excision Repair
The first step of...
Genome Copying Errors


